Breast Cancer Clinical Program Archives - Page 20 of 27

ouise M. Henderson, MSPH, PhD, is a UNC Lineberger member and assistant professor in the UNC School of Medicine Department of Radiology.

A study published in JAMA Oncology found that pre-menopausal women who were diagnosed with breast cancer following a biennial screening mammogram were likely to have more advanced tumors than woman screened annually. UNC Lineberger researcher Louise Henderson was a co-author on the study, which was co-led by researchers at the University of California-Davis School of Medicine and the Dana-Farber Cancer Institute.

Tom, Wilson and Nancy “Cancer is a moving target,” says Tom Chewning, “But Dr. Carey has a laser-like focus on both high-level research and excellent clinical care. That’s what we want to support: the ongoing, intellectual pursuit of better outcomes."

After Tom and Nancy Chewning's daughter, Wilson, was diagnosed with breast cancer, they began to research the best treatment options for her. Their search led them to UNC Lineberger and Dr. Lisa Carey. Now with Wilson cancer-free, the Chewnings are investing in the Dr. Lisa Carey Fund for Breast Cancer Innovations so that others may also benefit from the most cutting-edge breast cancer research and treatment.

Charles M. Perou, PhD, is a UNC Lineberger member and the May Goldman Shaw Distinguished Professor of Molecular Oncology.

UNC Lineberger Comprehensive Cancer Center researchers helped lead an effort by The Cancer Genome Atlas Network of researchers to map the genetic drivers of invasive lobular carcinoma, the second most commonly diagnosed invasive form of breast cancer. They found that this cancer type may be at least three different diseases that differ in their microenvironmental features and outcomes.

Breast cancer survivors stretch out before beginning a session with Get Real & Heal

Even in the midst of treatment, many cancer patients are finding that exercise helps them to feel better, both physically and emotionally. Through the Get Real & Heal program, UNC researchers are digging deeper into the science behind why moving more can make a positive impact on patients' overall health and well-being.

Barbara with her daughter, Lanie, and mother, Carole Ann, at the Avon 39 Walk Walk to End Breast Cancer in San Francisco

As a breast cancer survivor, Barbara Martin has established a tradition – walking 39 miles to raise awareness and funds for breast cancer – that has become very special to her. This challenge became even more special this year, as her mother and daughter were both by her side along the way.

One of my favorite quotes is ‘Life begins at the end of your comfort zone.’ It’s my mission to inspire other people to do what they think they can’t.”|Amy at the 2015 Boston Marathon with her family.

Amy Charney had already registered to run the 2015 Boston Marathon when she was told she had breast cancer. But not even that diagnosis and active treatment would keep her from crossing the finish line in her hometown of Boston.

In a new pre-clinical study published today, UNC Lineberger researchers show that they can exploit cancer’s reliance on a particular protein to help fight triple negative breast cancer. They believe the protein could be a potential new drug target.

Andrew Olshan, PhD, Professor and Associate Director for Population Sciences at UNC Lineberger Comprehensive Cancer Center

A multicenter research team known as the African American Breast Cancer Epidemiology and Risk Consortium (AMBER), which includes UNC Lineberger's Andrew Olshan, PhD has uncovered differences in ER-positive & ER-negative breast cancer pathways. The team examined whether relationships between age at menarche and breast cancer are the same for tumors that are ER-positive or ER-negative, particularly among African-American women. ER-negative breast cancer is generally more aggressive and known to be associated with a poorer prognosis than ER-positive disease.

The assessment, co-published by UNC Lineberger member and professor of gynecologic oncology Groesbeck Parham, MD, not only identifies the roadblocks to treatment, but also provides a path to overcoming them.

Tag: Breast Cancer Clinical Program

Menopausal status may be more important than age in breast cancer screening frequency, study finds

Tom and Nancy Chewning: Looking at cancer in a whole new light

Genomic analysis paves way for personalized treatment of invasive lobular carcinoma

Providing hope and healing through health

Rock stars for a day

Amy Charney

Who says you can’t go home?

Potential drug target identified for aggressive breast cancer type

Early menarche may be important in development of aggressive breast cancer in African-American women

Assessment is first to measure breast and cervical cancer landscape in Zambia